PTK2 (pY397) Antibody

Este producto es parte de PTK - protein tyrosine kinase
Product Graph
299€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
PTK2 (pY397) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx243046
tested applications
ELISA, WB

Description

PTK2 (pY397) Antibody is a Monoclonal Antibody against PTK2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
PTK2
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 1-2 weeks.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q05397
Alias
FAK,FADK,FAK1,FRNK,FADK 1,PPP1R71,p125FAK,pp125FAK,Focal adhesion kinase-related nonkinase,Protein phosphatase 1 regulatory subunit 71,Protein-tyrosine kinase 2
Background
Antibody anti-PTK2
Status
RUO

Descripción

Protein Tyrosine Kinase 2 (PTK2), also known as FAK (Focal Adhesion Kinase), is a non-receptor tyrosine kinase that plays a critical role in cell adhesion, migration, and signal transduction. PTK2 is primarily located at focal adhesion sites and is activated in response to integrin signaling and growth factor receptors. Structurally, PTK2 consists of an N-terminal FERM domain for membrane association, a central kinase domain for catalytic activity, and a C-terminal focal adhesion targeting (FAT) domain that mediates protein-protein interactions. PTK2 is crucial in cytoskeletal organization, integrin-mediated signaling, and cell motility, particularly in processes such as embryogenesis, wound healing, and angiogenesis. PTK2 is upregulated in various cancers, including breast, colorectal, and glioblastoma, where it promotes cell proliferation, survival, and metastasis. Dysregulation of PTK2 signaling can contribute to chemoresistance and increased tumor progression, making it a potential therapeutic target. In non-cancer contexts, PTK2 is essential for immune cell function, particularly for T-cell activation and macrophage responses. Additionally, PTK2 is implicated in neurological processes, such as synaptic plasticity and neuron survival. Its diverse roles make PTK2 a key mediator of cellular communication and mechanotransduction.

Related Products

EH0579

Human PTK2 (Focal adhesion kinase 1) ELISA Kit

Ver Producto
FNab02950

PTK2 antibody

Ver Producto
FNab10444

PTK2 antibody

Ver Producto